How to Read a Peptide Certificate of Analysis: A 2026 Guide
A certificate of analysis is the lab report that proves what's in a vial. Here's how to read one, field by field.
A peptide certificate of analysis, or CoA, is a lab report that shows what's actually in a vial. Read it in four steps. First, check the batch or lot number matches the label. Second, read the HPLC purity, where 98% or higher is the mark to look for. Third, confirm identity by mass spectrometry. Fourth, for injectables, look for sterility and endotoxin results. The testing lab should be independent and accredited. A real CoA is what separates pharmacy-grade from grey-market.
What a peptide certificate of analysis is
A certificate of analysis is a batch-specific lab report that confirms a peptide's identity, purity, and safety. It answers one question: is what's on the label really in the vial? A complete CoA lists the tests run on a single lot, the results, and the lab that ran them. It's the paper trail behind a peptide, and it's the fastest way to tell a tested, pharmacy-grade product from an untested one.
The CoA matters most because the peptide market has two very different lanes. On one side are prescribed, pharmacy-compounded peptides that are tested and released with paperwork. On the other are "research-grade" or "not for human use" vials sold with no prescriber and no pharmacy, where identity and purity are unverified. Reading a CoA is how you tell which lane you're in. For more on that split, see research-grade vs pharmacy-grade peptides.

The one-line versionA good CoA names the lot, shows purity by HPLC, confirms identity by mass spec, adds sterility and endotoxin for injectables, and comes from a named, accredited lab.
The fields on a peptide CoA, explained
A CoA is a short list of fields, and each one confirms a different thing. You don't need a chemistry degree to read it. You need to know what each row means and what a good result looks like. The table below covers the fields you'll see on most peptide CoAs.
| Field on the CoA | What it confirms | What good looks like |
|---|---|---|
| Batch / lot number | Ties the test to your exact vial | Matches the number printed on the label |
| HPLC purity | How much of the vial is the target peptide | 98% or higher, with a chromatogram shown |
| Mass spectrometry | The peptide is the right molecule | Observed mass matches the theoretical mass |
| Water / moisture content | Supports accurate dosing | Listed as a clear percentage |
| Sterility (injectables) | No living microbes | Reported as a pass to USP standards |
| Endotoxin (injectables) | No fever-causing toxins | Below the FDA limit, reported in EU/mg |
| Testing lab | Who ran the tests | Named, independent, and accredited |
How to read HPLC purity
HPLC purity tells you how much of the vial is the peptide you paid for. HPLC stands for high-performance liquid chromatography. It separates the sample into its parts and measures each one. A result of "98% by HPLC" means at least 98% of what the instrument detected matches the target peptide, and the rest is minor impurities.
- Look for a number of 98% or higher for most peptides.
- Look for the actual chromatogram, not just the percentage. A clean chromatogram shows one tall, sharp peak with a flat baseline.
- Be cautious if you see several large peaks or a noisy, wandering baseline. That can point to impurities or a degraded batch.
- Check the detection wavelength if it's listed. Peptides are usually read at 214 to 220 nanometers, which is standard.
Why the picture mattersA purity number alone can be typed by anyone. A chromatogram image is harder to fake and lets you see the peak with your own eyes. Prefer CoAs that show it.
How to read the mass spectrometry result
Mass spectrometry confirms the peptide is the right molecule. HPLC tells you how pure the sample is, but not whether it's the correct sequence. Mass spec weighs the molecule with high precision, so it catches a wrong or truncated peptide that might still look pure. A CoA should show two numbers: the theoretical mass (what the peptide should weigh) and the observed mass (what the instrument measured). They should match closely.
- Compare theoretical mass and observed mass. On modern instruments they should agree to within about 5 parts per million.
- Be wary of a result reported only as a loose tolerance like plus or minus 0.1%. On a large peptide, that window is wide enough to hide a wrong sequence.
- HPLC and mass spec work together. A peptide can be 99% pure and still be the wrong molecule, or the right molecule buried in impurities. You want both tests to pass.
If both purity and identity check out, you've cleared the two most important hurdles. For injectables, there are a few more, covered next.
Sterility, endotoxin, and potency for injectables
Injectable peptides need extra tests because anything that goes under the skin must be sterile and free of certain toxins. A CoA for an injectable should add sterility, endotoxin, and potency to the purity and identity results. These are the checks that a prescribing pharmacy runs, and a research-grade vial almost never has.
- Sterility: confirms no living microbes are present. Reported as a pass under USP sterility standards.
- Endotoxin: confirms the product is free of bacterial fever-causing toxins. Reported in EU/mg and kept below the FDA limit for injectables.
- Potency: confirms the actual amount of peptide is within the expected range, so dosing is accurate.
- Residual solvents: some CoAs also list a solvent panel (for example TFA, acetonitrile, and DMF) to confirm manufacturing residues are within limits.
Compounded and testedLicensed 503A pharmacies compound under USP 797 and USP 800 standards and send sterile batches to accredited labs for sterility, endotoxin, and potency testing before release. Learn more in what is a 503A pharmacy.
Red flags on a peptide CoA
Some CoAs look official but don't hold up. A few clear red flags tell you a document isn't worth trusting. If you see any of these, treat the purity claim as unverified, no matter how polished the page looks.
| Red flag on a CoA | Why it matters |
|---|---|
| No lab name, or a lab you can't find online | You can't verify who ran the tests or whether they exist |
| A purity number with no chromatogram | The percentage can't be checked against the actual data |
| Mass spec given only as a loose tolerance | A wide window can hide the wrong sequence |
| Lot number doesn't match the vial label | The report may belong to a different batch |
| No sterility or endotoxin on an injectable | The vial hasn't cleared the tests injectables require |
| A generic CoA reused for every product | A real CoA is specific to one lot, not one-size-fits-all |
A missing CoA is itself a red flag. Any seller that can't produce batch-specific paperwork is one to walk away from. For more on this, see how to spot fake peptides.
How to verify the testing lab
A CoA is only as trustworthy as the lab behind it. The single best check is to confirm the testing lab is real, independent, and accredited. A CoA from a lab you can't verify isn't really third-party proof, even if the numbers look good.
- Look for accreditation. In the US, an ISO/IEC 17025 accredited lab has proven its testing is reliable. You can confirm accreditation through the American Association for Laboratory Accreditation (A2LA).
- Search the lab's name and address on your own. A legitimate lab has a real, findable presence.
- For strong verification, contact the lab using details you found yourself, not the ones printed on the CoA, and ask them to confirm the batch and date.
- Prefer independent third-party labs over in-house results. Independence is the whole point of a CoA.
If you'd rather not do this legwork on every order, that's exactly the gap a licensed provider fills. More on verifying sources: how to verify a peptide source.
Where compounded peptides stand in 2026
Compounded peptides are not FDA-approved, and that's normal for compounded medicines. 503A pharmacies legally compound prescribed medicines for individual patients. That does not mean untested or unsafe. A pharmacy-grade compounded peptide still gets identity, purity, and (for injectables) sterility and endotoxin testing, documented on a CoA.
The rules are moving in 2026. On April 15, 2026, the FDA removed 12 peptides from the 503A Category 2 list. The Pharmacy Compounding Advisory Committee (PCAC) is reviewing 7 of them (BPC-157, TB-500, KPV, MOTS-C, DSIP, Semax, and Epitalon) at its meeting on July 23 to 24, 2026. Important: removal from Category 2 is not approval, and it is not the same as being placed on the authorized 503A bulk substances list. It's one step in an ongoing review.
Two lanes, one document503A pharmacies compound for an individual patient's prescription; 503B outsourcing facilities make larger batches. Either way, the CoA is how quality gets documented. Full detail in FDA peptide regulations for 2026 and PCAC explained.
How pru handles the certificate of analysis
pru is built so you don't have to chase paperwork. A licensed physician reviews your intake and confirms whether a peptide is a fit, an FDA-regulated 503A pharmacy compounds and fills the prescription, and a certificate of analysis comes with your order.
You select the peptide, guided by pru's education; the physician confirms clinical fit. That's the legitimate path, documented end to end. Learning to read a CoA means you already care about what goes into your body, and pru exists to make that proactive, informed choice the accessible one.
- Physician-prescribed: a licensed clinician confirms fit before anything is filled.
- Pharmacy-grade: an FDA-regulated 503A pharmacy compounds your peptide and runs release testing.
- CoA with every order: identity, purity, and, for injectables, sterility and endotoxin, documented per batch.
- At cost: peptides are billed at cost, itemized, with no markup, on a membership of about $50 per month.
You can browse the categories on the pru catalog or read up on specific peptides like sermorelin, GHK-Cu, and NAD+. Membership details are on the pricing page. When you're ready to take the next step, the licensed physicians, pharmacy-grade medicine, and at-cost pricing make the careful choice the easy one.
Related reading
Keep going with the guides that pair naturally with reading a CoA:
- Research-grade vs pharmacy-grade peptides
- How to verify a peptide source
- How to spot fake peptides
- Are compounded peptides safe?
- What is a 503A pharmacy?
- FDA peptide regulations for 2026
- Browse the pru catalog
Common questions
Sources & further reading
- https://www.fda.gov/advisory-committees/human-drug-advisory-committees/pharmacy-compounding-advisory-committee
- https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding-under-section-503a-fdc-act
- https://www.orrick.com/en/Insights/2026/04/FDA-Announces-Removal-of-12-Peptides-from-Category-2-and-Schedules-PCAC-Meetings
- https://www.usp.org/compounding
- https://a2la.org/
- https://www.legitscript.com/
- joinpru.com/blog